Berlex Laboratories Cyclosporin for MS Study terminated by sponsor due to renal toxicity, 1986. Betaseron reduced relapses and active MRI lesions, and improved visual memory. Berlex Laboratories Tizanidine for Spasticity in MS Study finished, 1995. Contact Athena Neurosciences for drug information. Linomide reduced clinical and MRI activity in MS, but caused heart attacks.
Drug is available.
Terbutaline may reduce fatigue in MS and correct immune abnormalities. Contact Biogen for results of this trial. Contact sponsor for results of this trial. We are enrolling patients to participate in the study of terbutaline as a treatment for myasthenia gravis. This drug is give by mouth and is used to treat patients with asthma.